Loading provider…
Loading provider…
Hematology & Oncology Physician in Rosedale, MD
NPI: 1336254424HQ Phone
Get MD Marvin's Phone NumberMobile
Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).
Authors: Vassiliki Papadimitrakopoulou, Primo Lara, Alfred Newman, Philip Hoffman, Charu Aggarwal
Publication Date: 2019-02-25
Authors: Adashek, Michael L, Feldman, Marvin
Journal: J Oncol Pract
Publication Date: 2019-07-16
Authors: Kathleen Yost, Rakesh Gaur, Marsha Reyngold, Michael Haddock, Joshua Meyer, John Suh, David Sherr, Christopher Crane, Rex Mowat, Samir Narayan, Yuhchyau Chen, William Regine
Journal: Oncologist
Publication Date: 2019-12-16
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: placebo, DRUG: nab-paclitaxel, DRUG: alpelisib
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Veliparib, OTHER: Placebo Administration
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, DRUG: Cisplatin, DRUG: Capecitabine, DRUG: Etoposide